HealthLynked Corp.
HLYK
$0.04
-$0.0004-0.99%
| Weiss Ratings | HLYK - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | HLYK - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | HLYK - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.01 | |||
| Price History | HLYK - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -18.37% | |||
| 30-Day Total Return | -35.69% | |||
| 60-Day Total Return | 33.33% | |||
| 90-Day Total Return | 14.29% | |||
| Year to Date Total Return | 122.22% | |||
| 1-Year Total Return | -32.20% | |||
| 2-Year Total Return | -57.89% | |||
| 3-Year Total Return | -82.42% | |||
| 5-Year Total Return | -63.64% | |||
| 52-Week High % Change | -58.86% | |||
| 52-Week Low % Change | 1,201.94% | |||
| Price | HLYK - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.10 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Oct 10, 2024 | |||
| 52-Week High Price (Date) | Jun 10, 2024 | |||
| Valuation | HLYK - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 11.38M | |||
| Enterprise Value | 14.70M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.03 | |||
| Earnings Per Share Growth | 83.33% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 3.45 | |||
| Price/Book (Q) | -5.85 | |||
| Enterprise Value/Revenue (TTM) | 4.43 | |||
| Price | $0.04 | |||
| Enterprise Value/EBITDA (TTM) | -3.69 | |||
| Enterprise Value/EBIT | -3.40 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | HLYK - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 281.95M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | HLYK - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 800 928 7144 | |||
| Address | 1265 Creekside Parkway Naples, FL 34108 | |||
| Website | www.healthlynked.com | |||
| Country | United States | |||
| Year Founded | 1996 | |||
| Profitability | HLYK - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -130.24% | |||
| Profit Margin | -186.32% | |||
| Management Effectiveness | HLYK - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -64.00% | |||
| Return on Equity | -- | |||
| Income Statement | HLYK - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 3.27M | |||
| Total Revenue (TTM) | 3.32M | |||
| Revenue Per Share | $0.01 | |||
| Gross Profit (TTM) | 1.06M | |||
| EBITDA (TTM) | -3.98M | |||
| EBIT (TTM) | -4.32M | |||
| Net Income (TTM) | -6.19M | |||
| Net Income Avl. to Common (TTM) | -6.19M | |||
| Total Revenue Growth (Q YOY) | -55.71% | |||
| Earnings Growth (Q YOY) | -1,122.49% | |||
| EPS Diluted (TTM) | -0.03 | |||
| EPS Diluted Growth (Q YOY) | -1,328.57% | |||
| Balance Sheet | HLYK - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 15.00K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 1.82M | |||
| Total Preferred Equity (Q) | 0.00 | |||
| Total Equity (Q) | -1.93M | |||
| Current Ratio (Q) | 0.479 | |||
| Book Value Per Share (Q) | -$0.01 | |||
| Total Assets (Q) | 2.76M | |||
| Total Current Liabilities (Q) | 3.81M | |||
| Total Debt (Q) | 3.33M | |||
| Total Liabilities (Q) | 4.69M | |||
| Total Common Equity (Q) | -1.94M | |||
| Cash Flow | HLYK - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 1.18M | |||
| Cash from Financing (TTM) | 2.72M | |||
| Net Change in Cash (TTM) | -36.30K | |||
| Levered Free Cash Flow (TTM) | -2.33M | |||
| Cash from Operations (TTM) | -3.94M | |||
